Carestart

Covid-19 IgM/IgG

Rapid Diagnostic Test for the Detection of SARS-CoV-2 IgM/IgG Ab
ORDER NOW

ACCESS BIO’S CARESTART™ COVID-19 lgM/lgG

RAPID COVID-19 TESTING TOOL

NOW FDA EMERGENCY USE AUTHORIZED

SARS-CoV-2, A highly contagious novel virus, had severely impacted the U.S. and global healthcare system and economy. A rapid in vitro testing is a key component to identify and mitigate the spread. The CareStart™ Covid 19 IgM/IgG Rapid Diagnostic Test for the Detection of SARS-CoV-2 IgM/IgG Ab provides a fast and easy diagnostic tool for COVID-19 in the limited testing environment.

  • Fast and easy to use in a qualified CLIA setting
  • Detect and differentiate IgM/IgG antibody specific to SARS-CoV-2.
  • Requires small sample volume (10 uL of venous whole blood, serum, or plasma)
  • Results available in 10 minutes.
  • No equipment or training required.
  • Identify and monitor individual’s previous infection history and immune response to COVID-19.
  • Clinical performance (NIH/NCI) of 100% sensitivity and 97.5% specificity.
  • CE certified.
ORDER NOW
ORDER NOW

TEST
PRINCIPLES

The CareStart™ Covid 19 IgM/IgG Rapid Diagnostic Test for the Detection of SARS-CoV-2 IgM/IgG Ab is a lateral flow immunochromatographic assay which can differentiate SARS-CoV-2 Immunoglobin IgM and IgG antibodies in human blood specimens in a single test within 10 minutes.